Back to Journals » Journal of Hepatocellular Carcinoma » Volume 4

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Total article views   Abstract views HTML views PDF downloads Totals
4,660 Dovepress* 3,435 645+ 339 4,080
PubMed Central* 0 580 92 580
Totals 3,435 1,225 431 4,660
*Since 12 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
210 0 0 0 2 208

View citations on PubMed Central and Google Scholar